These homozygous genome-edited XPO1C528S Jurkat cells were viable and showed a >250 fold resistance to SINE compounds, demonstrating that the anti-cancer activity of SINE compounds effectively results from XPO1 inhibition [12]. This evidence concerns the gene XPO1 and cancer.